Evidence map›Paper›PMID 40356465›Full record

ArticleBritish journal of health psychology2025

Acceptability of acceptance and commitment therapy for medication-decision-making and quality of life in women with breast cancer: A qualitative process evaluation.

Sophie M C Green, Louise H Hall, Rachel Ellison, Jane Clark, Hollie Wilkes, Suzanne Hartley, Jay Naik, Sarah Buckley, Charlotte Hirst, Sue Hartup and 6 more

Abstract read
In one paragraph

Article in British journal of health psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sophie M C GreenLeeds Institute of Health Science, University of Leeds, Leeds, UK.ORCID 0000-0002-2622-5377
Louise H HallLeeds Institute of Health Science, University of Leeds, Leeds, UK.
Rachel EllisonDepartment of Health Sciences, University of York, York, UK.
Jane ClarkDepartment of Clinical and Health Psychology, St James's University Hospital, Leeds, UK.
Hollie WilkesClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Suzanne HartleyClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Jay NaikDepartment of Oncology, Harrogate & District Foundation Trust, Lancaster, UK.
Sarah BuckleyDepartment of Clinical Research, Mid Yorkshire Hospitals NHS Trust, Wakefield, UK.
Charlotte HirstDepartment of Health Sciences, University of York, York, UK.
Sue HartupSt James's University Hospital, Leeds, UK.
Richard D NealAPEx (Exeter Collaboration for Academic Primary Care), Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Galina VelikovaLeeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Amanda FarrinClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Michelle CollinsonClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Christopher D GrahamDepartment of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.
Samuel G SmithLeeds Institute of Health Science, University of Leeds, Leeds, UK.

Funding

Breast Cancer NowBritish Lung FoundationMacmillan Cancer SupportNational Institute for Health and Care Research NIHR300588Yorkshire Cancer Research L417
6 · The paper itself

Abstract

objectivesAdjuvant endocrine therapy (AET) reduces breast cancer recurrence, but side effects and distress impact adherence. We co-designed an Acceptance and Commitment Therapy (ACT) intervention to support medication decision-making and quality of life in women prescribed AET (ACTION). In a qualitative process evaluation nested in the pilot trial, we aimed to elicit participant experiences of receipt and therapists experience of delivery of ACTION to enhance our understanding of acceptability.

designRemote semi-structured interviews were conducted with women with breast cancer who received ACTION (n = 20) and trial therapists (n = 3).

methodsInterviews were guided by the Theoretical Framework of Acceptability (TFA). Rapid Assessment Procedure (RAP) sheets were completed after each interview to map responses onto TFA constructs, and sections of interviews were selectively transcribed. Individual RAP sheets were collated to identify key findings.

resultsACTION was generally liked, in particular, the group format (affective attitude). Participants and therapists felt ACTION was low effort, but therapists acknowledged the burden associated with trial procedures (burden). Participants generally felt able to engage with ACTION, and therapists felt they were able to deliver it (self-efficacy). The perceived effectiveness of ACTION on well-being was good, but was mixed for impact on treatment adherence (perceived effectiveness). Participants and therapists understood the aims of ACTION (coherence), and ACTION generally aligned with therapists' values (ethicality). Therapists questioned who would be most appropriate to deliver ACTION (opportunity costs).

conclusionACTION was acceptable to women with breast cancer and trial therapists. Rapid qualitative analysis can facilitate efficient process evaluations in time- and resource-limited contexts.

Indexed as

Acceptance and Commitment TherapyAntineoplastic Agents, HormonalBreast NeoplasmsDecision MakingPatient Acceptance of Health CareQuality of LifeAdultAgedChemotherapy, AdjuvantFemaleHumansMiddle AgedPilot ProjectsQualitative ResearchAntineoplastic Agents, Hormonalacceptabilityacceptance and commitment therapyadjuvant endocrine therapybreast cancerprocess evaluationrapid assessment procedure

Identifiers

PMID40356465
PMCPMC12070145

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.